RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of HSTO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Histogen Inc. stock price on Wednesday moving 100.00% between high and low
(Updated on May 01, 2024)

Sell candidate since Apr 29, 2024 Loss -43.04% PDF

The Histogen Inc. stock price fell by -43.04% on the last day (Wednesday, 1st May 2024) from $0.351 to $0.200. During the last trading day the stock fluctuated 100.00% from a day low at $0.100 to a day high of $0.200. The price has risen in 4 of the last 10 days but is still down by -60% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -14 thousand shares and in total, 2 thousand shares were bought and sold for approximately $463.00 .

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.160 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 18.10% during the next 3 months and, with a 90% probability hold a price between $0.189 and $0.604 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

HSTO Signals & Forecast

There are few to no technical positive signals at the moment. The Histogen Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.329 and $0.399. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 30, 2024, and so far it has fallen -43.04%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Histogen Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.150. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $ may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.100 between high and low, or 100.00%. For the last week the stock has had daily average volatility of 20.01%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HSTO) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Histogen Inc. to open at $0.167, and during the day (based on 14 day Average True Range), to move between $0.138 and $0.262, which gives a possible trading interval of +/-$0.0615 (+/-30.77%) up or down from last closing price. If Histogen Inc. takes out the full calculated possible swing range there will be an estimated 61.54% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $0.150, some $0.0499 (24.95%) from the current price of $0.200, our system finds the risk reward attractive.

Is Histogen Inc. stock A Buy?

The Histogen Inc. stock holds several negative signals and despite the positive trend, we believe Histogen Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.119 Sell Candidate Unchanged

Predicted Opening Price for Histogen Inc. of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
$0.167 ( 16.67%) $0.200

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for HSTO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.267 33.33 %
R2 0.228 14.23 %
R1 0.205 2.43 %
Current price: 0.200
Support S1 0.128 -35.77 %
S2 0.105 -47.57 %
S3 0.0667 -66.67 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 0.200
Support S1 0.150 -24.95%
S2 0 .
S3 0 .

FAQ

What is the symbol for Histogen Inc. Stock and on which exchange is it traded?
The symbol for Histogen Inc. is HSTO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Histogen Inc. Stock?
The Histogen Inc. stock holds several negative signals and despite the positive trend, we believe Histogen Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Histogen Inc. Stock?
Histogen Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Histogen Inc. Stock.

What's the current price of Histogen Inc. Stock?
As of the end of day on the May 01, 2024, the price of an Histogen Inc. (HSTO) share was $0.200.

What is the 52-week high and low for Histogen Inc. Stock?
The 52-week high for Histogen Inc. Stock is $1.05 and the 52-week low is $0.0501.

What is the market capitalization of Histogen Inc. Stock?
As of the May 01, 2024, the market capitalization of Histogen Inc. is 1.5M.

When is the next earnings date for Histogen Inc.?
The upcoming earnings date for Histogen Inc. is Aug 08, 2024.
Click to get the best stock tips daily for free!

About Histogen Inc.

Histogen. Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. It offers HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; HST-004, a cell conditioned media solution to treat spinal disc repair; and Emricasan, an orally active pan-caspase inhibitor for the tr... HSTO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT